A prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B live cold-adapted (liquid CAIV-T) administered concomitantly with live, attended, poliovrus vaccine in healthy children

Simple item page
dc.contributor.authorBreiman, Robert F.
dc.contributor.authorBrooks, Abdullah
dc.contributor.authorNaheed, Aliya
dc.date.accessioned2008-02-05T08:14:32Z
dc.date.available2008-02-05T08:14:32Z
dc.date.issued2001
dc.identifier.otherhttp://dspace.icddrb.org/jspui/handle/123456789/619
dc.identifier.urihttp://hdl.handle.net/123456789/619
dc.language.isoen
dc.sourceICDDR,B Institutional Repository
dc.subjectInfluenza
dc.subjectInfluenzavirus A,B
dc.subjectInfluenza Vaccine
dc.subjectChildren
dc.subjectBangladesh
dc.titleA prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B live cold-adapted (liquid CAIV-T) administered concomitantly with live, attended, poliovrus vaccine in healthy children
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
ICDDRBProtocol-2001-011.pdf
Size:
1.9 MB
Format:
Adobe Portable Document Format
Download

Collections

Infectious diseases and vaccine sciences research protocols